Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Clinical trial NCT07661056 · RECRUITING
Trial details
- NCT number
- NCT07661056
- Sponsor
- Biohaven Therapeutics Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-26
- Primary completion
- 2028-01-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.